PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • LAA closure devices - Market size and forecast 2018-2023 • PFO closure devices - Market size and forecast 2018-2023 • ASD closure devices - Market size and forecast 2018-2023 • Other heart defect closure devices - Market size and forecast 2018-2023 • Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • Europe - Market size and forecast 2018-2023 • North America - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: MARKET TRENDS • Increasing number of clinical trials to expand geographic coverage of heart defect closure devices • Rising focus on R&D of bioabsorbable occluders • Use of 3D imaging in heart defect closure procedures PART 11: VENDOR LANDSCAPE • Overview • Landscape disruption PART 12: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • AtriCure, Inc. • Boston Scientific Corporation • Cardia, Inc. • Lifetech Scientific • W. L. Gore & Associates, Inc. PART 13: APPENDIX • Research methodology • List of abbreviations   Exhibit 01: Years in consideration Exhibit 02: Global medical devices market Exhibit 03: Segments of global medical devices market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: LAA closure devices - Market size and forecast 2018-2023 ($ millions) Exhibit 21: LAA closure devices - Year-over-year growth 2019-2023 (%) Exhibit 22: PFO closure devices - Market size and forecast 2018-2023 ($ millions) Exhibit 23: PFO closure devices - Year-over-year growth 2019-2023 (%) Exhibit 24: ASD closure devices - Market size and forecast 2018-2023 ($ millions) Exhibit 25: ASD closure devices - Year-over-year growth 2019-2023 (%) Exhibit 26: Other heart defect closure devices - Market size and forecast 2018-2023 ($ millions) Exhibit 27: Other heart defect closure devices - Year-over-year growth 2019-2023 (%) Exhibit 28: Market opportunity by product Exhibit 29: Customer landscape Exhibit 30: Market share by geography 2018-2023 (%) Exhibit 31: Geographic comparison Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Europe - Year-over-year growth 2019-2023 (%) Exhibit 34: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 35: North America - Year-over-year growth 2019-2023 (%) Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 37: Asia - Year-over-year growth 2019-2023 (%) Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 39: ROW - Year-over-year growth 2019-2023 (%) Exhibit 40: Key leading countries Exhibit 42: Market opportunity Exhibit 43: Decision framework Exhibit 44: Impact of drivers and challenges Exhibit 45: Vendor landscape Exhibit 46: Landscape disruption Exhibit 47: Vendors covered Exhibit 48: Vendor classification Exhibit 49: Market positioning of vendors Exhibit 50: Abbott - Vendor overview Exhibit 51: Abbott - Business segments Exhibit 52: Abbott - Organizational developments Exhibit 53: Abbott - Geographic focus Exhibit 54: Abbott - Segment focus Exhibit 55: Abbott - Key offerings Exhibit 56: Abbott - Key customers Exhibit 57: AtriCure, Inc. - Vendor overview Exhibit 58: AtriCure, Inc. - Product segments Exhibit 59: AtriCure, Inc. - Organizational developments Exhibit 60: AtriCure, Inc. - Geographic focus Exhibit 61: AtriCure, Inc. - Segment focus Exhibit 62: AtriCure, Inc. - Key offerings Exhibit 63: AtriCure, Inc. - Key customers Exhibit 64: Boston Scientific Corporation - Vendor overview Exhibit 65: Boston Scientific Corporation - Business segments Exhibit 66: Boston Scientific Corporation - Organizational developments Exhibit 67: Boston Scientific Corporation - Geographic focus Exhibit 68: Boston Scientific Corporation - Segment focus Exhibit 69: Boston Scientific Corporation - Key offerings Exhibit 70: Boston Scientific Corporation - Key customers Exhibit 71: Cardia, Inc. - Vendor overview Exhibit 72: Cardia, Inc. - Product segments Exhibit 73: Cardia, Inc. - Key offerings Exhibit 74: Cardia, Inc. - Key customers Exhibit 75: Lifetech Scientific - Vendor overview Exhibit 76: Lifetech Scientific - Business segments Exhibit 77: Lifetech Scientific - Organizational developments Exhibit 78: Lifetech Scientific - Geographic focus Exhibit 79: Lifetech Scientific - Segment focus Exhibit 80: Lifetech Scientific - Key offerings Exhibit 81: Lifetech Scientific - Key customers Exhibit 82: W. L. Gore & Associates, Inc. - Vendor overview Exhibit 83: W. L. Gore & Associates, Inc. - Product segments Exhibit 84: W. L. Gore & Associates, Inc. - Organizational developments Exhibit 85: W. L. Gore & Associates, Inc. - Key offerings Exhibit 86: W. L. Gore & Associates, Inc. - Key customers Exhibit 87: Validation techniques employed for market sizing Exhibit 88: List of abbreviations  

Abbott AtriCure Inc. Boston Scientific Corporation Cardia Inc. Lifetech Scientific W. L. Gore & Associates Inc.